Picture of IDEXX Laboratories logo

IDXX — IDEXX Laboratories News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Idexx Laboratories Inc Reports Results For The Quarter Ended In September 30: Earnings Summary

* IDEXX Laboratories Inc  IDXX.OQ  reported quarterly
adjusted
earnings of $2.80​​ per share for the quarter ended September
30, higher than the same quarter last year, when the company
reported EPS of $2.53.  The mean expectation of ten analysts for
the quarter was for earnings of $2.68 per share. Wall Street
expected results to range from $2.64  to $2.71 per share.
    * Revenue rose 6.6% to $975.54 million from a year ago;
analysts
expected $979.18 million. 
    * IDEXX Laboratories Inc's reported EPS for the quarter was
$2.80​.
    * The company reported quarterly net income of $232.84
million.
    * IDEXX Laboratories Inc shares had fallen by 10.7% this
quarter and lost 18.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 3.4%
in the last three months.​ 
    * In the last 30 days, three analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 7
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is  "hold."

Wall Street's median 12-month price target for IDEXX
Laboratories Inc is $503.50 
This summary was machine generated from LSEG data November 1 at
03:30 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      2.68           2.80           Beat
 Jun. 30 2024      2.88           3.02           Beat
 Mar. 31 2024      2.67           2.81           Beat
 Dec. 31 2023      2.12           2.32           Beat

Recent news on IDEXX Laboratories

See all news